Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow, 3 November 2026 (Including F&O)

  • November 2, 2026
  • Posted by: Kunal Singla
  • Category: Uncategorized
No Comments
Nifty Pharma Prediction for Tomorrow, 3 November 2026 (Including F&O)

Nifty Pharma closed at 27,105.00, down 0.07%. Nifty 50 rose 1.68%. India VIX rose 1.31% to 15.50. Next session is tomorrow, Tuesday 3 November.

Quick Answer

The nifty pharma prediction for tomorrow is steady for tomorrow, 3 November 2026. Nifty Pharma was little changed at 27,105.00 on Monday, down 0.07 percent, ending a five-day run of gains. The index traded between 26,936.90 and 27,272.15, a range of about 335 points.

This nifty pharma prediction for tomorrow follows a Monday, 2 November 2026 session in which the Nifty Pharma index was little changed at 27,105.00, down 0.07 percent, ending a five-day run of gains, while the Nifty 50 rose 1.68 percent.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are tracking sector-specific triggers and F&O positioning ahead of the session tomorrow, which falls on Tuesday, 3 November 2026.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Monday Told Us
  • Nifty Pharma Prediction for Tomorrow: Key Levels
  • Key Drivers for Tomorrow
  • Stocks and Triggers to Watch in the Nifty Pharma Space
  • How Monday’s Broader Session Unfolded
  • Analyst View for Tomorrow
  • Why This Is Written for Tomorrow
  • Risks to This Prediction
  • Conclusion
  • Frequently Asked Questions
    • What is the nifty pharma prediction for tomorrow?
    • Why is this a prediction for tomorrow, 3 November 2026?
    • Why was Nifty Pharma flat on Monday?
    • What are the key Nifty Pharma levels for tomorrow?
    • Is this a buy or sell call?

What Monday Told Us

  • Nifty Pharma closed at 27,105.00, down 0.07 percent on 2 November 2026.
  • The broader Nifty 50 rose 1.68 percent.
  • India VIX rose 1.31 percent to 15.50.

Nifty Pharma Prediction for Tomorrow: Key Levels

Nifty Pharma traded between 26,936.90 and 27,272.15 on Monday, against a previous close of 27,124.85, and settled at 27,105.00. On the downside, 26,936.90 is the first reference level to watch if the day’s move is tested. On the upside, 27,124.85 and 27,272.15 mark the nearest resistance. Univest’s analysts treat these as reference points drawn from Monday’s trading range, not as targets.

Trend Support Resistance
Neutral 26,936.90 27,124.85, 27,272.15

The table uses Monday’s high, low and previous close for Nifty Pharma.

Key Drivers for Tomorrow

  • Nifty Pharma closed at 27,105.00, down 0.07 percent, with a high of 27,272.15 and a low of 26,936.90.
  • The index opened at 27,190.15, rose to its high and then faded, so early gains were not held.
  • The Nifty 50 rose 1.68 percent, so pharma lagged a strongly rising market.

Ankit Jaiswal and Kunal Singla suggest revisiting this nifty pharma prediction for tomorrow after the first thirty minutes of Tuesday’s trade.

Anyone following this nifty pharma prediction for tomorrow should keep the next session’s opening range in view before reading too much into early moves.

Stocks and Triggers to Watch in the Nifty Pharma Space

Nifty Pharma is a defensive-growth gauge. A flat close after five gains reads as a pause, though lagging a strong market is a mild caution. US generic pricing and export updates are the usual triggers.

In the F&O segment, the nearest Nifty options expiry is tomorrow, 3 November 2026, so option prices can swing sharply on expiry day. Among the strikes Univest checked, call open interest was highest at the 23,500 strike and put open interest was highest at the 23,000 strike, with a put-call ratio of approximately 1.66. India VIX rose 1.31 percent to 15.50, and Univest’s analysts treat these strikes as reference points, not predictions.

Univest’s analysts suggest treating this nifty pharma prediction for tomorrow as a preparation note for Tuesday, 3 November 2026, rather than a signal that changes overnight.

These are educational views, not buy calls, and each should be checked against your own risk plan before acting.

How Monday’s Broader Session Unfolded

The Nifty 50 closed at 23,440.80, up 1.68 percent, with a high of 23,440.80 and a low of 23,207.05, so it finished at the best level of the day. The Sensex closed at 75,692.78, up 1.66 percent, and the Bank Nifty closed at 55,002.20, up 0.58 percent. India VIX, the market’s fear gauge, rose 1.31 percent to 15.50, after ranging between 14.55 and 15.92 during the session. The Nifty 50 closed about 1.3 percent above its close of 23,146.15 on 16 October. The Nifty Midcap 50 rose 1.24 percent and the Nifty Next 50 rose 1.85 percent, so the rise was broad. Nifty Metal rose 3.21 percent and Reliance Industries rose 11.60 percent, while Nifty IT fell 0.50 percent and Nifty Private Bank fell 0.14 percent. The trigger for the broad rise was not independently confirmed.

This nifty pharma prediction for tomorrow will be most useful when read alongside the support and resistance table above.

Analyst View for Tomorrow

Kunal Singla suggests that the index can hold above 26,936.90, Monday’s low, with 27,272.15 the resistance to clear.

Ankit Jaiswal flags that a flat close after five gains is a pause rather than a reversal, so a hold above 26,937 matters.

A fair reading of this nifty pharma prediction for tomorrow is that Monday’s data sets the context, while Tuesday’s first hour decides how much of it carries forward.

Why This Is Written for Tomorrow

This nifty pharma prediction for tomorrow is written after the close on Monday, 2 November 2026, using Monday’s closing data, for the next trading session tomorrow, Tuesday, 3 November 2026. Treat it as a briefing to prepare for that session, not a live call that updates through the evening.

Track the Nifty Pharma Space on Univest Screeners

Readers comparing views should note that this nifty pharma prediction for tomorrow draws only on Monday’s closing numbers and the factors listed here.

Risks to This Prediction

  • After five gains, a pause or pullback is common.
  • A stronger rupee can hurt export earnings.
  • US regulatory news can move pharma stocks sharply.

As with any nifty pharma prediction for tomorrow, the opening minutes of Tuesday’s trade will confirm or challenge the levels discussed here.

The nifty pharma prediction for tomorrow also depends on India VIX, so a fresh rise in volatility would weaken the case made here.

Download the Univest iOS App or Univest Android App to get daily market recommendations and insightful research pieces.

Conclusion

The nifty pharma prediction for tomorrow leans steady into 3 November 2026, with broader Nifty 50 direction and India VIX as the key variables to track. Ankit Jaiswal and Kunal Singla will revisit this view once Tuesday’s opening trade confirms direction.

For traders, this nifty pharma prediction for tomorrow is a framework for planning risk, with position size and stop levels left to the individual.

Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

Frequently Asked Questions

What is the nifty pharma prediction for tomorrow?

Ans. It is steady for 3 November 2026, after Nifty Pharma closed at 27,105.00 on Monday, down 0.07 percent.

Why is this a prediction for tomorrow, 3 November 2026?

Ans. Because it is written after the close on Monday, 2 November 2026, for the next regular trading session on Tuesday, 3 November 2026.

Why was Nifty Pharma flat on Monday?

Ans. Nifty Pharma fell 0.07 percent after five straight gains while the Nifty 50 rose 1.68 percent. The specific trigger was not independently confirmed.

What are the key Nifty Pharma levels for tomorrow?

Ans. Monday’s low of 26,936.90 is the nearest support below the price, while the previous close of 27,124.85 and Monday’s high of 27,272.15 are the nearest resistance.

Is this a buy or sell call?

Ans. No. This is an educational outlook from Univest’s research team, not a buy or sell call. Traders should check any view against their own risk plan before acting.



Nifty Pharma
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply